Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer

Most Accessed Articles

New Anti-VEGF Drugs in Ophthalmology

Volume: 21   Issue: 12
Pp: 1194-1200
Claudio Campa *
DOI: 10.2174/1389450121666200428101738

Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer

Volume: 21   Issue: 3
Pp: 258-278
Ashish Ranjan Dwivedi, Amandeep Thakur, Vijay Kumar, Ira Skvortsova and Vinod Kumar*
DOI: 10.2174/1389450120666190821160730

Targeting Autophagic Pathways by Plant Natural Compounds in Cancer Treatment

Volume: 21   Issue: 12
Pp: 1237-1249
Fatemeh Forouzanfar and Seyed Hadi Mousavi*
DOI: 10.2174/1389450121666200504072635

N6-methyladenine RNA Modification (m6A): An Emerging Regulator of Metabolic Diseases

Volume: 21   Issue: 11
Pp: 1056-1067
Hui Zhong, Hui-Fang Tang and Yin Kai*
DOI: 10.2174/1389450121666200210125247

The Epigenetic Modification of Epigallocatechin Gallate (EGCG) on Cancer

Volume: 21   Issue: 11
Pp: 1099-1104
Linqi Yang, Wenqi Zhang, Saiyam Chopra, Deeepjyot Kaur, Huibing Wang, Meng Li, Pingping Chen* and Wei Zhang*
DOI: 10.2174/1389450121666200504080112

Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion

Volume: 22   Issue: 2
Pp: 192-201
Upinder Kaur, Sankha Shubhra Chakrabarti*, Bisweswar Ojha, Bhairav Kumar Pathak, Amit Singh, Luciano Saso and Sasanka Chakrabarti
DOI: 10.2174/1389450121666200924113243

COVID-19 and Renal Diseases: An Update

Volume: 22   Issue: 1
Pp: 52-67
Letícia Bitencourt, Ana Luisa Pedrosa, Stephanie Bruna Camilo Soares de Brito, Ana Cláudia Fontoura Fróes, Sarah Tayná de Carvalho, Giulio Gori Fonseca, Guilherme Costa Ferreira, Pollyanna Faria Fradico and Ana Cristina Simões e Silva*
DOI: 10.2174/1389450121999201013151300

Edaravone May Prevent Ferroptosis in ALS

Volume: 21   Issue: 8
Pp: 776-780
Snežana Spasić*, Aleksandra Nikolić-Kokić, Srđan Miletić, Zorana Oreščanin-Dušić, Mihajlo B. Spasić, Duško Blagojević and Zorica Stević
DOI: 10.2174/1389450121666200220123305

Application of Artificial Intelligence in Targeting Retinal Diseases

Volume: 21   Issue: 12
Pp: 1208-1215
Francesco Saverio Sorrentino, Giuseppe Jurman, Katia De Nadai, Claudio Campa, Cesare Furlanello and Francesco Parmeggiani*
DOI: 10.2174/1389450121666200708120646

Anti-VEGF and Retinal Dystrophies

Volume: 21   Issue: 12
Pp: 1201-1207
Maurizio Battaglia Parodi, Pierluigi Iacono* and Stefano Da Pozzo
DOI: 10.2174/1389450121666200428103334

Use of Anti-VEGF Drugs in Retinal Vein Occlusions

Volume: 21   Issue: 12
Pp: 1181-1193
Manuel AP Vilela*
DOI: 10.2174/1389450121666200428101343

TNF-α and IL-6: The Link between Immune and Bone System

Volume: 21   Issue: 3
Pp: 213-227
Tiantian Wang and Chengqi He*
DOI: 10.2174/1389450120666190821161259

Nanoparticle-based Drug Delivery Systems for Targeted Epigenetics Cancer Therapy

Volume: 21   Issue: 11
Pp: 1084-1098
Fengqian Chen, Yunzhen Shi, Jinming Zhang and Qi Liu*
DOI: 10.2174/1389450121666200514222900

Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling

Volume: 22   Issue: 2
Pp: 214-240
Shilpi Agrawal, Sanhita Maity, Zeina AlRaawi, Musaab Al-Ameer and Thallapuranam Krishnaswamy Suresh Kumar*
DOI: 10.2174/1389450121999201012201926

Fluoroquinolones: Blessings Or Curses

Volume: 21   Issue: 13
Pp: 1354-1370
Priyanka P. Majalekar* and Pramodkumar J. Shirote
DOI: 10.2174/1389450121666200621193355

Anti-VEGF Treatment in Corneal Diseases

Volume: 21   Issue: 12
Pp: 1159-1180
Giuseppe Giannaccare, Marco Pellegrini, Cristina Bovone, Rossella Spena, Carlotta Senni, Vincenzo Scorcia and Massimo Busin*
DOI: 10.2174/1389450121666200319111710